A tribute to Dr. Stephen Harrison (1969-2024)

It is with great sorrow that we mourn the untimely passing of our friend and colleague Stephen Harrison, MD. Dr. Harrison was a beacon of inspiration and professionalism, leaving an indelible mark on all who had the privilege of working alongside him. He was one of the pioneers in the field of MASLD and MASH and has made extensive contributions to the field of hepatology more broadly. His dedication, expertise, and unwavering commitment to excellence set a standard for us all to follow. Beyond his impressive achievements, he was a thoughtful and generous person who embodied what we should all aspire to be as human beings. He was the kindest of friends – loyal, positive, reliable and hard working. Despite his indisputable success and contributions, he was humble and caring. The void left by his departure is immense, and he will be deeply missed by many of us and never forgotten. Our deepest condolences go out to his family, his wife, Renee, daughter Anna-Lauren and son, Taylor for their profound loss. Zobair Younossi MD Mary Rinella MD Marcelo Kugelmas MD Jeffrey Lazarus PhD On behalf of Chronic Liver Disease Foundation and the Global NASH Council

Annual Liver Connect 2024 Conference

This weekend, Chronic Liver Disease Foundation concluded its highly successful Annual Liver Connect 2024 Conference. This 3-day meeting was attended by 500 in person attendees and 200 virtual attendees.  The meeting was full of cutting edge sessions covering a variety of topics liver disease which were delivered by over 70 renowned faculty. The meeting not only provided amazing scientific content for clinicians but also connected different stakeholders in the field of liver disease including providers, researchers, industry and patient representatives. The Liver Connect which is organized by CLDF is now established as one of the best annual meetings in liver disease. Looking forward to Liver Connect 2025.

The Global NASH Council Meeting During APASL 2024, Kyoto, Japan

The first Global NASH Council (GNC) meeting during APASL 2024 was held in Kyoto, Japan with a number of highly relevant topics related to MASLD/NAFLD discussed by regional leaders. GNC and its network of global collaborators will continue to expand their projects to address Steatotic Liver Disease as one of the most important non-communicable diseases in the world.

15th National Hepatology Conference in Rize, Turkey

Dear Global NASH Council (GNC) and Global Liver Council Members, We would like to share with you the exciting news that the 15th National Hepatology Congress will be held as an outstanding scientific meeting with internationally renowned faculty members in Rize Türkiye (www.ulusalhepatoloji2024.org). Date: May 9-12, 2024 Location: Ramada by Wyndham Hotel Rize, Türkiye If you have the chance to attend in person, we would welcome you to join the Congress and be among us. Alternatively, you can join the events virtually and experience the high caliber sessions in various topics in liver disease delivered by world renowned experts. Don't miss this opportunity to participate in the exceptional educational opportunity to move the field of liver disease forward. For more information and to register for the congress, you can visit www.ulusalhepatoloji2024.org We invite every member of the GNC/GLC worldwide to join in this special scientific meeting and look forward to seeing you in person or virtually. Regards Kind Regards, Yusuf Yılmaz MD Chairman, 15th National Hepatology Congress Zobair M. Younossi MD, MPH Chairman, the Global NASH and Liver Councils

Update on The Global NASH Council

The Global NASH Council (GNC), the Global Liver Council (GLC) and the Center for Outcomes Research in Liver Diseases (CORLD) have been very active in the past year. Please click on the image to see the summary of our activities and projects.

ScholarGPS Lists GNC Members among Top Ranked Lifetime Scholars for Liver Disease and NAFLD

The Global NASH Council (GNC) and Global Liver Council members have consistently demonstrated exceptional academic productivity, producing a substantial body of high-impact evidence in liver disease and NAFLD/MASLD. Our influential work has not only garnered widespread recognition but has also inspired and influenced the research directions. In the latest data from ScholarGPS (2022), our members have been ranked at the top of the field of liver disease, NAFLD, fatty liver disease and hepatology. Highly Ranked Scholars™-Lifetime are eminent authors whose Top Percentage Ranks places them above 0.05% of all scholars due to highly significant impact and quality of their scholarly contributions based on lifetime contributions. Life Time Ranking-Category: Liver Disease RankingScholar #1Zobair M. Younossi #2Arun J. Sanyal #11Elisabetta Bugianesi #16Stephen A. Harrison #22Giulio Marchesini #26Luca Valenti #28Rohit Loomba #34Quentin M. Anstee #35Kenneth Cusi #36Jacob George #39Jian-Gao Fan #50Massimo Colombo #51Michael Trauner #58Yusuf Yilmaz Life Time Ranking-Category: Non-alcoholic fatty liver disease (NAFLD or MASLD) RankingScholar #1Zobair M. Younossi #2Arun J. Sanyal #8Elisabetta Bugianesi #9Rohit Loomba #13Stephen A. Harrison #14Quentin M. Anstee #18Jian-Gao Fan #21Kenneth Cusi #22Giulio Marchesini #23Luca Valenti #24Mary E. Rinella https://scholargps.com/scholars PDF

GNC Presentation at AASLD 2023

Members of the Global NASH Council and Global Liver Council from Center for Outcomes Research in Liver Disease presented 16 abstracts at the annual meeting (2023) of the American Association for the Study of Liver Disease in Boston Massachusetts, United States TitleAuthors 1Abstract #40938 Development Of A Primary Biliary Cholangitis-Specific Version Of Chronic Liver Disease Questionnaire: CLDQ-PBCZobair Younossi, Maria Stepanova, Issah Younossi, Andrei Racila 2Abstract #42850 Non-Alcoholic Steatohepatitis (Nash) Has Become The Most Common Indication For Liver Transplantation Among Candidates With Hepatocellular Carcinoma In The United StatesZobair M. Younossi, Reem Al Shabeeb, Katherine Eberly, Dipam Shah, Veronica Nguyen , Janus Ong, Saleh A Alqahtani, Linda Henry, Maria Stepanova 3Abstract #43328 A Rapid Rise In The Global Prevalence Of Nonalcoholic Fatty Liver Disease) And Non-Alcoholic Steatohepatitis Among Patients With Type 2 Diabetes Zobair M. Younossi, Pegah Golabi, Jillian Price, Soroor Owrangi, Nagashree Gundu Rao, Romona Satchi, James M. Paik 5Abstract #43839 PNPLA3-Rs738409 CG/GG Genotype Is Strongly Associated With Advanced Histologic Fibrosis And High Risk Enhanced Liver Fibrosis ScoreZobair M.Younossi, James M. Estep, Sean Felix, Brian P. Lam., Elena Younossi Nagashree Gundu-Rao, Leyla De Avila, Huong Pham, Becky Cable, Jillian Price, Andrei Racila, Maria Stepanova 7Abstract #44101 Cost-Effectiveness Of Identifying High-Risk Non-Alcoholic Fatty Liver Disease Patients In The United States Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader 8Abstract #45122 Individuals With Advanced Fibrosis Have Worse Fine Motor PerformanceAli A. Weinstein, Leyla De Avila, Jillian K. Price, Carey Escheik, Pegah Golabi, Lynn Gerber, Zobair M. Younossi 10Abstract #42842 Liver Transplantation Profile Among Teenagers In The United StatesMaria Stepanova, Dipam Shah, Reem Al Shabeeb, Katherine Eberly, Veronica Nguyen, Janus Ong, Saleh A Alqahtani, Zobair M. Younossi 11Abstract #42859 Liver Transplantation For Primary Biliary Cholangitis In The U.S. In 2008-2022 Maria Stepanova, Katherine Eberly , Dipam Shah, Reem Al Shabeeb, Veronica Nguyen, Janus Ong, Saleh A Alqahtani, Linda Henry, Zobair Younossi 12Abstract #44005 Quantitation Of Plasma Cells, Cytotoxic T Cells, And Kupffer Cells/Macrophages With Hepatic Fibrosis Stage In Non-Alcoholic SteatohepatitisJames M. Estep, Anne Masters, Lakshmi Alaparthi, Gary Bratthauer, Aybike Birerdinc, Fanny Monge, Cassandra Sharp, Daisong Tan, Hala Abdelaal, Zachary Goodman, Zobair M Younossi 13Abstract #44071 Food Insecurity And Household Income Substantially Increase The Risk Of NAFLD Among Adolescent Children In The U.S.James M. Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey V. Lazarus, Linda Henry, Zobair M. Younossi 14Abstract #44990 Alcoholic Liver Disease And Non-Alcoholic Fatty Liver Disease Were The Main Drivers Of Cirrhosis Related Deaths Before And During The Covid-19 Pandemic In The United StatesJames M. Paik, Dipam Shah, Katherine Eberly, Peagh Golabi, Linda Henry, Zobair Younossi 16Abstract #46884 Assessment Of Hospital Readmission Rates, Risk Factors, Causes And Cost After Discharge With Chronic Liver Disease: Analysis Of The Us Nationwide Readmissions DatabaseJames M. Paik, Becky Cable, Linda Henry, Leyla De Avila, Huong Pham, Zobair M. Younossi